A resolution expressing support for the designation of July 2023 as "National Sarcoma Awareness Month".

3/12/2024, 8:05 AM

This resolution expresses support for the designation of National Sarcoma Awareness Month. Sarcoma is a cancer of connective tissues, such as nerves, muscles, joints, fat, bones, and blood vessels.

Bill 118 SRES 249 is a resolution introduced in the US Congress that expresses support for the designation of July 2023 as "National Sarcoma Awareness Month". Sarcoma is a rare type of cancer that develops in the bones and soft tissues of the body. The resolution aims to raise awareness about sarcoma and the impact it has on individuals and families affected by the disease.

The resolution highlights the need for increased research funding, improved access to treatment options, and greater support for patients and their loved ones. It also recognizes the efforts of healthcare professionals, researchers, and advocacy organizations working to improve outcomes for sarcoma patients.

By designating July 2023 as "National Sarcoma Awareness Month", the resolution seeks to educate the public about the signs and symptoms of sarcoma, promote early detection and diagnosis, and encourage individuals to seek appropriate medical care. It also aims to honor the strength and resilience of sarcoma patients and their families, and to show solidarity with those affected by the disease. Overall, Bill 118 SRES 249 underscores the importance of raising awareness about sarcoma and supporting efforts to improve prevention, diagnosis, and treatment options for individuals facing this rare and challenging form of cancer.
Congress
118

Number
SRES - 249

Introduced on
2023-06-13

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

6/13/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Passed in Senate

Purpose and Summary

This resolution expresses support for the designation of National Sarcoma Awareness Month. Sarcoma is a cancer of connective tissues, such as nerves, muscles, joints, fat, bones, and blood vessels.

Bill 118 SRES 249 is a resolution introduced in the US Congress that expresses support for the designation of July 2023 as "National Sarcoma Awareness Month". Sarcoma is a rare type of cancer that develops in the bones and soft tissues of the body. The resolution aims to raise awareness about sarcoma and the impact it has on individuals and families affected by the disease.

The resolution highlights the need for increased research funding, improved access to treatment options, and greater support for patients and their loved ones. It also recognizes the efforts of healthcare professionals, researchers, and advocacy organizations working to improve outcomes for sarcoma patients.

By designating July 2023 as "National Sarcoma Awareness Month", the resolution seeks to educate the public about the signs and symptoms of sarcoma, promote early detection and diagnosis, and encourage individuals to seek appropriate medical care. It also aims to honor the strength and resilience of sarcoma patients and their families, and to show solidarity with those affected by the disease. Overall, Bill 118 SRES 249 underscores the importance of raising awareness about sarcoma and supporting efforts to improve prevention, diagnosis, and treatment options for individuals facing this rare and challenging form of cancer.
Alternative Names
Official Title as IntroducedA resolution expressing support for the designation of July 2023 as "National Sarcoma Awareness Month".

Policy Areas
Health

Potential Impact
Cancer
Commemorative events and holidays
Health promotion and preventive care

Comments

Recent Activity

Latest Summary9/15/2023

This resolution expresses support for the designation of National Sarcoma Awareness Month. Sarcoma is a cancer of connective tissues, such as nerves, muscles, joints, fat, bones, and blood vessels.


Latest Action6/13/2023
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2071; text: CR S2075)